Stocks / NASDAQ / BioCryst Pharmaceuticals, Inc.

BioCryst Pharmaceuticals, Inc.

Our Opinion

BioCryst Pharmaceuticals, Inc. is on the Cruelty Free Investing use of animals list because they conduct Pre-clinical studies of their drugs on animals to assess a product’s safety profile.


BioCryst Pharmaceuticals Inc said its experimental broad-spectrum antiviral drug showed promise against Ebola when tested in monkeys.

BioCryst Pharmaceuticals, Inc. announced in its shareholder information release that, ” In studies with treatment just prior to infection or delayed up to 4 days after infection, BCX4430 treated animals had significantly (p < 0.001) improved survival (80—100%) compared to animals receiving saline placebo (20-30%).” Read the full article.

Company Description

BioCryst Pharmaceuticals, Inc. is a biotechnology company, which designs, optimizes and develops novel drugs that block key enzymes involved in the pathogenesis of diseases with its focus on therapeutic areas with unmet medical needs. It integrates the disciplines of biology, crystallography, medicinal chemistry and computer modeling to discover and develop small molecule pharmaceuticals through the process known as structure-guided drug design. The company was founded in 1986 and is headquartered in Birmingham, AL. [Source: MarketWatch]